Jiaxin Zhu

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 04, 2020
Cost-effectiveness of pembrolizumab plus axitinib as first-line therapy for advanced renal cell carcinoma.

Jiaxin Zhu, Tiantian Zhang, Ning Wan

Pageof 1

Frequent Collaborators

1 joint publications

Jie Jiang